Similar articles

• Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.

  Pawlik G, Wienhard K, Herholz K, Wagner R, Heiss WD. Pawlik G, et al. Prog Brain Res. 1984;62:253-62. doi: 10.1016/S0079-6123(08)62181-0. Prog Brain Res. 1984. PMID: 6335919 No abstract available.
• [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].

  Yamaguchi T, Sasaki H, Uemura K, Shishido F, Inugami A, Ogawa T, Higano S, Mineura K, Kanno I, Murakami M. Yamaguchi T, et al. Kaku Igaku. 1986 Jun;23(6):829-32. Kaku Igaku. 1986. PMID: 3489854 Japanese. No abstract available.
• New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose).

  Takahashi H, Yamaguchi K, Wakui A, Maeda S, Yang PK, Ito M, Matsuzawa T, Fukuda H, Ido T. Takahashi H, et al. Sci Rep Res Inst Tohoku Univ Med. 1986 Dec;33(1-4):38-43. Sci Rep Res Inst Tohoku Univ Med. 1986. PMID: 3498212 No abstract available.
• 2-Deoxy-2-[18F]fluoro-D-glucose for metabolic studies: current status.

  Fowler JS, Wolf AP. Fowler JS, et al. Int J Rad Appl Instrum A. 1986;37(8):663-8. doi: 10.1016/0883-2889(86)90259-5. Int J Rad Appl Instrum A. 1986. PMID: 3021667 Review. No abstract available.
• Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.

  Schmidt KC, Lucignani G, Sokoloff L. Schmidt KC, et al. J Nucl Med. 1996 Feb;37(2):394-9. J Nucl Med. 1996. PMID: 8667082 Review. No abstract available.